Spencer Pharmaceutical (SPPH)

[LiquidOTC]

Our formulation is very easy to manufacture compared to existing formulations, in addition to being better for the patient therefore making the MET4 ideal for licensing," said Dr. Max Arella, President of Spencer Pharmaceutical Inc. "The licensing for our Met4 to these companies could yield substantial financial results in the very short term for our company and can be the driving force in making Spencer a world class pharmaceutical," further added Dr. Arella.